Lp(a) – Proof of the pudding is in the trial

Professor Joseph Witzum, University of California, San Diego, USA, provides a comprehensive review of Lp(a) research in cardiovascular disease, including initial findings with the antisense oligonucleotide, pelacarsen, in reducing Lp(a), and its ongoing clinical trials programme.